Heterozygosity for the neurofibromatosis 1 (NF1) tumor suppressor results in abnormalities in cell attachment, spreading and motility in astrocytes
Authors:
- David H. GutmannDGDavid H. Gutmann
- Yan Li WuYWYan Li Wu
- Nicolé M. HedrickNHNicolé M. Hedrick
Open Access
- 1 December 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 10 (26) , 3009-3016
Abstract
Individuals with the neurofibromatosis 1 (NF1) tumor predisposition syndrome develop low-grade pilocytic astrocytomas at an increased frequency. Previously, we demonstrated that astrocytes from mice heterozygous for a targeted mutation in the Nf1 gene (Nf1+/– astrocytes) exhibit a cell autonomous growth advantage associated with increased RAS pathway activation. In this report, we extend our initial characterization of the effect of reduced Nf1 gene expression on astrocyte function by demonstrating that Nf1+/– astrocytes exhibit decreased cell attachment, actin cytoskeletal abnormalities during the initial phases of cell spreading, and increased cell motility. Whereas these cytoskeletal abnormalities were also observed in Nf1–/– astrocytes, astrocytes expressing a constitutively active RAS molecule showed increased cell motility and abnormal actin cytoskeleton organization during cell spreading, but exhibited normal cell attachment. Based on ongoing gene expression profiling experiments on human astrocytoma tumors, we demonstrate increased expression of two proteins implicated in cell attachment, spreading and motility (GAP43 and T-cadherin) in Nf1+/– and Nf1–/– astrocytes. These results support the emerging notion that tumor suppressor gene heterozygosity results in abnormalities in cell function that may contribute to the pathogenesis of non-tumor phenotypes in NF1.Keywords
This publication has 40 references indexed in Scilit:
- Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytesGlia, 2001
- Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 optic pathway glioma task forceAnnals of Neurology, 1997
- Characterization of full‐length neurofibromin: tubulin inhibits Ras GAP activity.The EMBO Journal, 1993
- Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubulesSomatic Cell and Molecular Genetics, 1993
- The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteinsCell, 1990
- The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiaeCell, 1990
- The neurofibromatosis type 1 gene encodes a protein related to GAPCell, 1990
- A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutationsCell, 1990
- Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locusCell, 1990
- Growth-associated protein 43 is down-regulated in cultured astrocytesMetabolic Brain Disease, 1989